Gangnam Severance Hospital in Seoul is JCI-accredited and first in Asia to use the da Vinci Robotic System for kidney cancer surgery. Genetic screening starts from around A$2,900 for early detection. Treatments include laparoscopic nephrectomy, which is less invasive and aids faster recovery, typically around A$20,000–24,200. Robotic nephrectomy with da Vinci usually costs A$32,200–36,700 and offers precise tumour removal with smaller incisions. Free interpreter services and airport transfers over A$4,400 are provided for international patients.